The Chinese government banned in February clinical genetic testing by hospitals and other selected medical institutions. The announcement, which was posted on the China Food and Drug Administration website, cited prenatal testing as an example of the types of tests that are affected. Permission from the government is now required in most cases in order […]
R&D spending, both domestic and abroad, by Pharmaceutical Research and Manufacturers of America (PhRMA) firms in 2013 totaled $51,060 million, up 3.0% compared to a gain of 1.9% in 2012. In 2013, members increased domestic spending 6.9%, a change from 3.1% in 2012, to comprise 79% of total R&D. Spending abroad fell 9.1%, compared to […]
The US’s Protecting Access to Medicare Act of 2014 became law this month and shifts the determination of Medicare payments for clinical lab tests to a market-based system. Starting in January 2017, the Centers for Medicare & Medicaid Services (CMS) will set the Medicare payment rates for clinical lab tests by using the weighted median […]
As a step toward combating global warming, the Obama Administration has released its strategy to reduce methane-emissions in the US. The Administration’s goal is for emissions to be cut by 2020 to 17% below 2005 levels. The methane-reduction strategy for oil and gas production includes updating standards for public lands and supporting technologies for detecting […]
Analytik Jena entered the ICP market with the introduction of the PlasmaQuant PQ 9000 ICP-OES, which features a compact design and delivers high resolution, ease of use, flexibility and precision. The PQ9000 is a simultaneous ICP system that employs four key components: high-resolution optics, the V (vertical) Shuttle Torch, Dual View PLUS technology and a […]
Fourth quarter 2013 IBO Lab Equipment/Consumables Sales Index revenues grew 3.7%, 4.9% excluding currency, to $4,474 million. Adjusted operating profit rose 10.0% to $809 million. Operating margin gained 90 basis points to 16.4% of sales. Full-year 2013 Index sales grew 1.7%, 2.8% excluding currency, to $16,759 million. Adjusted operating profit rose 2.3% to $2,956 million. […]
Thousand Oaks, CA 3/31/14—Teledyne Instruments, a subsidiary of Teledyne Technologies, has acquired Photon Machines (PMI) for an undisclosed amount. PMI designs and manufactures laser-based sample-introduction equipment for laboratory instruments, including laser-ablation systems. “The acquisition of Photon Machines naturally complements our acquisition of Teledyne CETAC in August 2013 [see IBO 8/31/13],” said Teledyne Chairman, President and […]
Paris, France 4/1/14; Paris, France 4/7/14—Molecular diagnostics firm Genomic Vision has completed its IPO, listing its shares on the Euronext Paris stock exchange (see IBO 3/31/14). The company’s shares began trading on April 7 at a price of €15.00 ($20.55 = €0.73= $1) per share, the middle of the expected pricing range. The offering raised […]
Berwyn, PA and Middlefield, CT 4/11/14—AMETEK, a global manufacturer of electronic instruments and electromechanical devices, has agreed to acquire publicly held Zygo, a provider of optical metrology solutions, high-precision optics and optical assemblies. AMETEK will acquire Zygo’s outstanding common stock at price of $19.25 per share, a 31% premium over Zygo’s closing price on April […]
Washington, DC 4/1/14; Minneapolis, MN 4/4/14; Minneapolis, MN 4/15/14—The R&D Systems subsidiary of Techne, now doing business as Bio-Techne, has agreed to acquire Shanghai PrimeGene Biotech (PrimeGene) for an undisclosed amount. PrimeGene develops, manufactures and distributes recombinant proteins for research and diagnostic applications, and had 2013 sales of $4 million. “The PrimeGene business expands our […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
